RxDoctor Payments Data

Carley Austgen, PA

Physician Assistant · Munster, INNPI 1710548409

Payments from drug & device makers

$2,569in general payments, 2019–2025

Across 142 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1000
  • Vanda Pharmaceuticals Inc.$504
  • Teva Pharmaceuticals USA, Inc.$195
  • Neurocrine Biosciences, Inc.$180
  • Lundbeck LLC$125
  • Otsuka America Pharmaceutical, Inc.$121
  • plus $445 from 11 others

What the payments were for

  • Food & beverage$2,46996%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,569 in reported general payments places this provider in the 85th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$14,934
Medicare patients
79
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate16$130,157
VraylarCariprazine Hcl87$112,261
Invega TrinzaPaliperidone Palmitate13$108,716
RexultiBrexpiprazole38$60,548
FanaptIloperidone12$25,962
VyvanseLisdexamfetamine Dimesylate29$10,898
Aripiprazole71$7,635
Paliperidone ErPaliperidone27$6,833
Lurasidone Hcl25$6,331
BelsomraSuvorexant14$5,983
AzstarysSerdexmethylphen/Dexmethylphen12$4,941
Venlafaxine Hcl ErVenlafaxine Hcl127$2,026
Trazodone Hcl158$1,801
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine54$1,676
Buspirone Hcl142$1,629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$180$130,15716 claims
AbbVieVraylar$1,000$112,26187 claims
Johnson & JohnsonInvega Trinza$33$108,71613 claims
Otsuka America Pharmaceutical, Inc.Rexulti$121$60,54838 claims
Vanda Pharmaceuticals Inc.Fanapt$504$25,96212 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$14$10,89829 claims
Corium, LLCAzstarys$115$4,94112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →